Valuation: GKB Ophthalmics Limited

Market Cap 265M 2.76M 2.43M 2.25M 2.07M 3.91M 3.98M 26.77M 10.5M 130M 10.38M 10.16M 449M P/E 2024
-15.6x
P/E 2025 -4.32x
Enterprise Value 280M 2.93M 2.57M 2.38M 2.19M 4.14M 4.22M 28.35M 11.12M 138M 10.99M 10.75M 475M EV / Sales 2024
0.43x
EV / Sales 2025 0.29x
Free-Float
23.1%
Yield 2024 *
-
Yield 2025 -
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
14/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
11/08/23 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
1 day-1.83%
1 week-6.67%
Current month-8.38%
1 month-7.52%
3 months-21.31%
6 months+17.82%
Current year+14.95%
1 week 57.11
Extreme 57.11
62.85
1 month 57.11
Extreme 57.11
65.22
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 09/12/1981
Director of Finance/CFO - 31/03/2019
Chief Administrative Officer 62 31/05/2024
Director TitleAgeSince
Chairman 84 09/12/1981
Director/Board Member 57 23/07/1996
Director/Board Member 68 19/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-1.83%-6.67%-20.77%-34.30% 3.17M
-1.17%-1.85%-30.52%-3.23% 90.08B
+2.68%+1.75%-19.82%-23.34% 32.91B
+0.57%-1.89%-3.22%-26.95% 13.79B
-0.83%+1.15% - - 9.91B
-4.41%-15.80%-27.15%+494.52% 1.97B
-1.21%-4.51%-32.48%-66.39% 1.41B
-2.53%-1.88%+20.03%+1.25% 897M
-1.02%-2.38%-38.26%-28.23% 846M
+0.48%-1.94%+43.93%-31.49% 764M
Average -0.95%-2.62%-12.03%+31.31% 15.26B
Weighted average by Cap. -0.26%-0.99%-24.71%-4.19%

Financials

2024 2025
Net sales 883M 9.22M 8.09M 7.49M 6.89M 13.04M 13.29M 89.28M 35.01M 433M 34.62M 33.87M 1.5B 1.09B 11.39M 9.99M 9.25M 8.51M 16.1M 16.41M 110M 43.24M 535M 42.76M 41.82M 1.85B
Net income -28.1M -294K -258K -239K -219K -415K -423K -2.84M -1.12M -13.8M -1.1M -1.08M -47.66M -70.45M -736K -646K -598K -550K -1.04M -1.06M -7.13M -2.8M -34.6M -2.76M -2.7M -119M
Net Debt -57.22M -598K -524K -486K -447K -845K -862K -5.79M -2.27M -28.1M -2.24M -2.2M -97.04M 15.59M 163K 143K 132K 122K 230K 235K 1.58M 619K 7.66M 612K 598K 26.44M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
170
Date Price Change Volume
13/07/26 58.90 -1.83% 1,656
10/07/26 ₹60.00 -1.61% 518
09/07/26 ₹60.98 +4.60% 4
08/07/26 ₹58.30 -2.74% 520
07/07/26 ₹59.94 -0.68% 1,950